Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review
Despite growing interest, substantial heterogeneity limits current evidence for medicinal cannabis in mental health. This review highlights key gaps, underscoring the need for robust, well-powered RCTs with extended follow-up to clarify its role in the management of mental ill health.
Authors
- Christine Mary Hallinan (ORCID: https://orcid.org/0000-0002-0471-4444)
- David Jonathan Castle (ORCID: https://orcid.org/0000-0002-3075-1580)
- Yvonne Bonomo (ORCID: https://orcid.org/0000-0003-2583-0687)
- Sophie Cooling
Institutions
- University of Tasmania (AU)
- Royal Women's Hospital (AU)
- The University of Melbourne (AU)
- St Vincent's Hospital Melbourne (AU)
Publication Details
- Journal
- Clinical Drug Investigation
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1007/s40261-025-01501-3
- Citations
- 1
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39